-0.67%
7.52%
-2.25%
-25.45%
-19.62%
-10.05%
49.52%

Company Description

Elevance Health Inc.operates as a health benefits company.It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives.


It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions.The company was formerly known as Anthem, Inc.and changed its name to Elevance Health Inc.


in June 2022.Elevance Health Inc.was founded in 1944 and is headquartered in Indianapolis, Indiana.

Market Data

Last Price 396.65
Change Percentage -0.67%
Open 398.31
Previous Close 399.32
Market Cap ( Millions) 91992
Volume 691454
Year High 567.26
Year Low 362.21
M A 50 388.51
M A 200 483.61

Financial Ratios

FCF Yield 0.95%
Dividend Yield 1.64%
ROE 14.24%
Debt / Equity 4.87%
Net Debt / EBIDTA -14.34%
Price To Book 2.24
Price Earnings Ratio 15.47
Price To FCF 105.6
Price To sales 0.52
EV / EBITDA 1.96

News

Business Breakdown

Expected Mid-Term Growth

Segment nΒ°1 -> Health Benefits

Expected Growth : 6.5 %

What the company do ?

Elevance Health Inc. offers various health benefits, including medical, dental, vision, and pharmacy coverage, as well as wellness programs and disease management services.

Why we expect these perspectives ?

Elevance Health Inc.'s 6.5% growth is driven by increasing demand for health benefits, expansion into new markets, and strategic acquisitions. Additionally, the company's focus on digital transformation, cost savings initiatives, and growing government contracts also contribute to its growth. Furthermore, the rising need for affordable healthcare and the aging population are tailwinds for the company's health benefits segment.

Segment nΒ°2 -> CarelonRx

Expected Growth : 6.8 %

What the company do ?

CarelonRx is a pharmacy benefit management service from Elevance Health Inc., offering customized pharmacy solutions to improve health outcomes and reduce costs.

Why we expect these perspectives ?

CarelonRx's 6.8% growth is driven by increasing adoption of value-based care, expansion of Medicare Advantage and Medicaid programs, and growing demand for pharmacy benefit management services. Additionally, Elevance Health's strategic investments in digital health and analytics capabilities, as well as its strong relationships with healthcare providers, contribute to the segment's growth.

Segment nΒ°3 -> Eliminations

Expected Growth : 0.0 %

What the company do ?

Eliminations from Elevance Health Inc. refer to the removal of redundant or duplicate costs, revenues, or expenses between subsidiaries, resulting in a more accurate financial representation.

Why we expect these perspectives ?

Elevance Health Inc.'s elimination growth rate of 0.0% is driven by stagnant market demand, intense competition, and lack of innovation in the healthcare services sector. Additionally, the company's inability to reduce costs and improve operational efficiency has hindered its growth potential.

Segment nΒ°4 -> Carelon Services

Expected Growth : 7.2 %

What the company do ?

Carelon Services from Elevance Health Inc. provides healthcare management services, including care coordination, benefits management, and population health management, to improve healthcare outcomes and reduce costs.

Why we expect these perspectives ?

Carelon Services' 7.2% growth is driven by increasing demand for value-based care, expansion of Medicare Advantage and Medicaid programs, and strategic partnerships. Additionally, Elevance Health's investments in digital health and analytics capabilities, as well as its focus on population health management, are contributing to the segment's growth.

Segment nΒ°5 -> Reconciling Items

Expected Growth : 0.0 %

What the company do ?

Reconciling Items from Elevance Health Inc. refers to the process of identifying and resolving discrepancies between expected and actual financial transactions, ensuring accurate financial reporting and compliance.

Why we expect these perspectives ?

Elevance Health Inc.'s stagnant growth is attributed to intense competition in the healthcare industry, high operating expenses, and lack of innovation in their product offerings. Additionally, the company's failure to adapt to changing regulatory requirements and increasing customer expectations have hindered their ability to drive growth.

Segment nΒ°6 -> Corporate and Other

Expected Growth : 5.8 %

What the company do ?

Corporate and Other from Elevance Health Inc. refers to the unallocated corporate expenses, investments, and other non-operating items not attributed to its health insurance business segments.

Why we expect these perspectives ?

Elevance Health Inc.'s Corporate and Other segment growth of 5.8% is driven by increased investments in digital health initiatives, expansion of government programs, and strategic acquisitions. Additionally, cost savings from operational efficiencies and favorable tax rates also contribute to the segment's growth.

Elevance Health Inc. Products

Product Range What is it ?
Anthem Medicare Advantage Medicare Advantage plans that offer additional benefits and lower out-of-pocket costs
Anthem Medicaid Government-sponsored health insurance for low-income individuals and families
Anthem Individual and Family Plans Health insurance plans for individuals and families who don't have employer-sponsored coverage
Anthem Group Insurance Employer-sponsored health insurance plans for businesses of all sizes
Elevance Health Pharmacy Benefits Pharmacy benefits management services that help reduce prescription drug costs
Elevance Health Care Management Care management services that help improve health outcomes and reduce costs
Elevance Health Data and Analytics Data and analytics services that help improve health outcomes and reduce costs

Elevance Health Inc.'s Porter Forces

The threat of substitutes for Elevance Health Inc. is medium due to the presence of alternative healthcare services and products. However, the company's diversified portfolio and strong brand recognition mitigate this threat.

The bargaining power of customers is low for Elevance Health Inc. due to the company's strong market position and the lack of buyer concentration in the healthcare industry.

The bargaining power of suppliers is medium for Elevance Health Inc. due to the presence of multiple suppliers and the company's ability to negotiate prices. However, the company's dependence on certain suppliers for critical components may limit its bargaining power.

The threat of new entrants is low for Elevance Health Inc. due to the high barriers to entry in the healthcare industry, including regulatory hurdles and the need for significant capital investments.

The intensity of rivalry is high for Elevance Health Inc. due to the presence of several established players in the healthcare industry, leading to intense competition for market share and customers.

Capital Structure

Value
Debt Weight 38.99%
Debt Cost 5.28%
Equity Weight 61.01%
Equity Cost 7.90%
WACC 6.88%
Leverage 63.91%

Historical Valuation

Price/Earnings Ratio

Margin Valuation

Peers Valuation

Competitors

Company Rational
UNH UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment …
CVS CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer …
HUM Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The …
CNC Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage …
MCK McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment …

Peers Metrics

DCF BETA

Parameters

Short Term Growth
Short term Time
Long-Term Growth
WACC
Target Price
396.65$
Current Price
396.65$
Potential
-0.00%

Expected Cash-Flows

Scoring Insights

Peers Group Analysis

πŸ₯‡

McKesson Logo
McKesson
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

πŸ₯ˆ

UnitedHealth Logo
UnitedHealth
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

πŸ₯‰

Elevance Health Logo
Elevance Health
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

4

CVS Health Logo
CVS Health
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

5

Centene Logo
Centene
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

6

Humana Logo
Humana
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->